[Emerging mycoses]

The incidence of new pathogenic agents in the fungi group has been on the rise over the past few years. This can be explained by the similar increase in elderly patients, precarious situations or immunodeficient states, together with the high degree of instrumentation in hospitals and the indiscriminate use of antibiotics and antimycotics both to cure and prevent. This study includes emerging fungi, isolated in the aforementioned individuals, which belong to the filamentous and dimorphic fungi groups, and yeasts. In view of their number, only the main ones are mentioned, together with the clinical manifestations they produce and the grounds for their diagnosis and treatment.